Taysha Gene Therapies shares owned by T. Rowe Price Associates
Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by T. Rowe Price Associates
from 13F filings
Historical chart of T. Rowe Price Associates investment in Taysha Gene Therapies
Tip: Access up to 7 years of quarterly data
All positions including Taysha Gene Therapies held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Taysha Gene Therapies by T. Rowe Price Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $711k | 159k | 4.47 |
| 2025-12-31 | $670k | 122k | 5.50 |
| 2025-09-30 | $373k | 114k | 3.28 |
| 2025-06-30 | $196k | 85k | 2.32 |
| 2025-03-31 | $103k | 74k | 1.39 |
| 2024-12-31 | $114k | 65k | 1.75 |
| 2024-09-30 | $121k | 60k | 2.03 |
| 2024-06-30 | $2.9M | 1.3M | 2.25 |
| 2024-03-31 | $3.2M | 1.1M | 2.87 |
| 2023-12-31 | $2.2M | 1.2M | 1.77 |
| 2023-09-30 | $3.9M | 1.2M | 3.16 |